Information  X 
Enter a valid email address
  Print      Mail a friend       More announcements

Thursday 12 March, 2020

Societe Generale SA

Form 8.3 - Allergan plc

RNS Number : 8939F
Societe Generale SA
12 March 2020
 

  Ap19

 

 

FORM   8.3

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

 

1.  KEY   INFORMATION

 

Nameofpersondealing (Note 1)

Société Générale S.A.

Companydealtin

   Allergan plc

Classofrelevantsecuritytowhichthe dealingsbeingdisclosedrelate (Note 2)

US$0.0001 ordinary shares

Date of dealing

11/03/2020

 

2.  INTERESTS AND SHORT POSITIONS

 

(a)  Interests   and   short   positions   (following   dealing)   in   the   class   of   relevant   security   dealt   in   (Note 3)

 

 

Long

Short

Number

(%)

Number

(%)

(1) Relevant securities

2,204,851

0.67

61,074

0.02

(2) Derivatives (other than options)

88,000

0.03

1,495,757

0.45

(3) Options and agreements to purchase/sell

58,500

0.02

0

0.00

Total

*2,968,421

*0.90

1,556,831

0.47

 

* Include the holding of 617,070 shares on borrow products

 

 

(b)  Interests and short positions in relevant securities of the company, other than the class dealt in  (Note 3)

 

Class of relevant security:

Long

Short

 

Number

(%)

Number

(%)

(1) Relevant securities

 

 

 

 

(2) Derivatives (other than options)

 

 

 

 

(3) Options and agreements to purchase/sell

 

 

 

 

Total

 

 

 

 

 

 

Ap20

 

 

1.  DEALINGS  (Note   4)

 

(a)  Purchases and sales

 

Purchase/sale

Number of relevant securities

Price per unit USD (Note 5)

Purchase

4,786

185.5

Purchase

100

187.03

Purchase

93

186.52

Purchase

7

186.52

Purchase

6

187.06

Purchase

100

187.29

Purchase

94

187.06

Purchase

100

187.22

Purchase

25

185.83

Purchase

75

185.83

Purchase

100

187.11

Purchase

98

186.8

Purchase

2

186.8

Purchase

100

186.77

Purchase

10

187.66

Purchase

90

187.66

Purchase

100

186.06

Purchase

100

186.84

Purchase

100

186.57

Purchase

100

186.59

Purchase

100

186.81

Purchase

100

187.24

Purchase

80

186.76

Purchase

100

187.85

Purchase

20

186.76

Purchase

80

185.5

Purchase

33

185.5

Purchase

100

186.53

Purchase

100

187.04

Purchase

100

187.32

Purchase

100

187.31

Purchase

100

187.32

Purchase

100

186.84

Purchase

14

185.47

Purchase

100

185.41

Purchase

100

185.32

Purchase

100

185.54

Purchase

86

185.47

Purchase

100

187.71

Purchase

100

187.02

Purchase

100

186.63

Purchase

100

186.57

Purchase

100

187.15

Purchase

33

187.02

Purchase

2

187.02

Purchase

2

187.02

Purchase

63

187.02

Purchase

100

187.53

Purchase

100

187

Purchase

100

186.87

Purchase

100

187.24

Purchase

100

186.37

Purchase

7

187.37

Purchase

100

186.86

Purchase

100

187.71

Purchase

100

187.64

Purchase

100

185.56

Purchase

45

186.9

Purchase

55

186.9

Purchase

68

185.542

Purchase

167

184.912

Purchase

5,713

185.5

Sale

23

185.57

Sale

800

185.5

Sale

100

185.49

Sale

100

185.35

Sale

100

185.55

Sale

100

185.16

Sale

99

185.85

Sale

100

185.5

Sale

100

188.14

Sale

10

187.16

Sale

14

187.16

Sale

76

187.16

Sale

100

187.15

Sale

100

187.15

Sale

100

187.04

Sale

100

187.97

Sale

100

185.71

Sale

100

185.55

Sale

100

187.09

Sale

75

186.91

Sale

25

186.9

Sale

10

186.67

Sale

11

186.55

Sale

100

186.66

Sale

100

186.57

Sale

100

187.25

Sale

92

186.02

Sale

90

186.66

Sale

47

187.15

Sale

50

187.15

Sale

3

187.15

Sale

100

187.08

Sale

1

187.1

Sale

100

186.68

Sale

99

187.1

Sale

38

187.24

Sale

8

186.02

Sale

89

186.55

Sale

100

186.63

Sale

100

186.54

Sale

100

186.54

Sale

100

186.58

Sale

100

186.94

Sale

24

186.69

Sale

100

186.81

Sale

100

185.55

Sale

100

186.53

Sale

100

185.85

Sale

1

187.22

Sale

396

186.53

Sale

198

186.53

Sale

99

186.53

Sale

198

186.53

Sale

99

186.53

Sale

2

185.5

Sale

62

186.53

Sale

749

185.5

Sale

100

186.61

Sale

100

185.29

Sale

100

186.82

Sale

100

187

Sale

100

185.01

Sale

100

187.03

Sale

95

186.96

Sale

100

186.94

Sale

100

187.05

Sale

100

184.85

Sale

100

186.97

Sale

100

186.78

Sale

100

186.97

Sale

100

187.17

Sale

100

187.2

Sale

100

187.2

Sale

100

187.2

Sale

100

187.14

Sale

100

185.43

Sale

100

187.05

Sale

94

187.2

Sale

90

185.91

Sale

10

185.93

Sale

100

187.08

Sale

100

187.7

Sale

196

186.741837

Sale

246

187.084504

Sale

100

187

Sale

13,790

185.5

Total Purchases

15,254

 

Total Sales

22,909

 

 

 

(b)  Derivatives transactions (other than options transactions)

 

Productname,

e.g. CFD

Natureoftransaction

(Note 6)

Numberofrelevantsecurities

(Note 7)

Priceperunit USD

(Note 5)

 

 

 

 

 

(c)  Options transactions in respect of existing relevant securities

 

 

(i)  Writing, selling, purchasing or varying

 

Productname,

e.g. call option

Writing, selling,purchasing,varyingetc.

Numberofsecurities towhichtheoptionrelates (Note 7)

Exercise price

Type, e.g.American,Europeanetc.

Expiry date

Optionmoney paid/receivedperunit (Note 5)

 

 

 

 

 

 

 

 

 

(ii)  Exercising

 

Productname,

e.g. call option

Numberofsecurities

Exercisepriceper unit (Note 5)

 

 

 

 

 

(d)  Other dealings (including transactions in respect of new securities) (Note 4)

 

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

 

 

 

 

Ap21

2.  OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 

 

 

 

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any

 derivative referred to on this form is referenced. If none, this should be stated.

 

 

 

 

 

 

 

 

 

 

Is a Supplemental Form 8 attached?  (Note   9)     Yes

 

Dateofdisclosure

12/03/2020

Contact name

Société Générale - Disclosure team

Telephone number

+33 1 42 14 92 74

If aconnectedEFM,nameofofferee/offerorwithwhichconnected

 

If aconnectedEFM,statenatureofconnection (Note 10)

 

 

 

 

 

 

 

 

 

 

Ap23

 

SUPPLEMENTAL   FORM 8

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL 

ACT,   1997, TAKEOVER RULES, 2013

 

 

 

 

DETAILS   OF OPEN POSITIONS

 

(This   form   should   be   attached   to   Form   8.1(a)   & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)

 

OPEN POSITIONS  (Note   1)

 

 

 

Productname,

e.g. call option

Written, orpurchased

Numberofrelevant securitiestowhichtheoptionorderivativerelates

Exercise price (Note 2)

Type, e.g.American,Europeanetc.

Expiry date

Listed Put Option

Sale

40,000

175

American options

15/01/2021

Listed Put Option

Sale

18,500

190

American options

15/01/2021

 

 

Notes

 

1.  Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.

 

2.  For all prices and other monetary amounts, the currency must be stated.

 

For full details of disclosure requirements, see Rule 8 of the  

Rules. If in doubt, consult the Panel.

 

 

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
ISEFIFIRVTIFLII

a d v e r t i s e m e n t